Susquehanna International Group
BIB icon

Susquehanna International Group’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Susquehanna International Group’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.08M Buy
13,212
+6,775
+105% +$561K ﹤0.01% 7693
2025
Q4 		$514K Sell
6,437
-7,663
-54% -$567K ﹤0.01% 8724
2025
Q3 		$840K Buy
14,100
+7,758
+122% +$417K ﹤0.01% 7767
2025
Q2 		$291K Sell
6,342
-7,535
-54% -$332K ﹤0.01% 10414
2025
Q1 		$669K Buy
13,877
+1,638
+13% +$87.8K ﹤0.01% 8255
2024
Q4 		$620K Sell
12,239
-309
-2% -$18.3K ﹤0.01% 8149
2024
Q3 		$800K Sell
12,548
-3,550
-22% -$229K ﹤0.01% 7348
2024
Q2 		$954K Buy
+16,098
New +$891K ﹤0.01% 6702
2024
Q1 		– Sell
-18,958
Closed -$1.1M – 12179
2023
Q4 		$1.08M Buy
18,958
+8,902
+89% +$417K ﹤0.01% 6804
2023
Q3 		$482K Buy
10,056
+1,384
+16% +$71.1K ﹤0.01% 8308
2023
Q2 		$451K Sell
8,672
-31,035
-78% -$1.71M ﹤0.01% 8554
2023
Q1 		$2.15M Buy
39,707
+22,850
+136% +$1.29M ﹤0.01% 4977
2022
Q4 		$973K Sell
16,857
-26,572
-61% -$1.5M ﹤0.01% 6250
2022
Q3 		$2.07M Buy
43,429
+28,399
+189% +$1.51M ﹤0.01% 4867
2022
Q2 		$727K Sell
15,030
-9,181
-38% -$467K ﹤0.01% 7317
2022
Q1 		$1.5M Buy
24,211
+5,240
+28% +$322K ﹤0.01% 6139
2021
Q4 		$1.54M Sell
18,971
-12,680
-40% -$1.09M ﹤0.01% 6152
2021
Q3 		$3M Sell
31,651
-2,732
-8% -$276K ﹤0.01% 4949
2021
Q2 		$3.39M Buy
34,383
+5,845
+20% +$510K ﹤0.01% 4768
2021
Q1 		$2.39M Buy
28,538
+6,744
+31% +$636K ﹤0.01% 5484
2020
Q4 		$1.88M Sell
21,794
-33,507
-61% -$2.59M ﹤0.01% 5228
2020
Q3 		$3.88M Buy
55,301
+29,428
+114% +$2.09M ﹤0.01% 3416
2020
Q2 		$1.88M Buy
25,873
+18,238
+239% +$1.16M ﹤0.01% 4614
2020
Q1 		$353K Sell
7,635
-51,984
-87% -$2.9M ﹤0.01% 7663
2019
Q4 		$3.68M Buy
+59,619
New +$3.18M ﹤0.01% 3401
2019
Q3 		– Sell
-19,642
Closed -$931K – 10144
2019
Q2 		$1.02M Sell
19,642
-11,675
-37% -$581K ﹤0.01% 5616
2019
Q1 		$1.74M Sell
31,317
-44,886
-59% -$2.42M ﹤0.01% 3975
2018
Q4 		$3.21M Buy
76,203
+46,879
+160% +$2.45M ﹤0.01% 2839
2018
Q3 		$2.04M Buy
29,324
+4,908
+20% +$321K ﹤0.01% 3951
2018
Q2 		$1.4M Buy
24,416
+12,478
+105% +$680K ﹤0.01% 4682
2018
Q1 		$657K Sell
11,938
-43,561
-78% -$2.61M ﹤0.01% 6093
2017
Q4 		$3.11M Buy
+55,499
New +$3.13M ﹤0.01% 3175
2017
Q3 		– Sell
-23,786
Closed -$1.35M – 8807
2017
Q2 		$1.27M Buy
23,786
+14,597
+159% +$712K ﹤0.01% 4773
2017
Q1 		$443K Buy
+9,189
New +$427K ﹤0.01% 6709
2016
Q4 		– Sell
-46,037
Closed -$1.97M – 9563
2016
Q3 		$2.23M Buy
46,037
+37,269
+425% +$1.77M ﹤0.01% 3384
2016
Q2 		$341K Sell
8,768
-33,506
-79% -$1.44M ﹤0.01% 6744
2016
Q1 		$1.73M Buy
42,274
+1,049
+3% +$46.4K ﹤0.01% 4050
2015
Q4 		$2.95M Buy
+41,225
New +$2.75M ﹤0.01% 3318
2015
Q3 		– Sell
-15,750
Closed -$1.34M – 9623
2015
Q2 		$1.42M Buy
+15,750
New +$1.36M ﹤0.01% 5432
2015
Q1 		– Sell
-30,228
Closed -$2.24M – 9401
2014
Q4 		$1.9M Buy
30,228
+1,696
+6% +$99.5K ﹤0.01% 4550
2014
Q3 		$1.48M Sell
28,532
-39,616
-58% -$1.92M ﹤0.01% 5167
2014
Q2 		$3.16M Buy
68,148
+16,010
+31% +$632K ﹤0.01% 3825
2014
Q1 		$2.08M Buy
+52,138
New +$2.37M ﹤0.01% 4282
2013
Q3 		– Sell
-35,396
Closed -$805K – 8387
2013
Q2 		$805K Buy
+35,396
New +$808K ﹤0.01% 5343

Other funds holding BIB

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
KFS
Kaizen Financial Strategies Campbell, California $308M AUM 41.73% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return

Susquehanna International Group's BIB Position: Q1 2026 in Review

Susquehanna International Group increased its ProShares Ultra NASDAQ Biotechnology (BIB) stake by 105% in Q1 2026, buying an estimated $561K and bringing the position to 13,212 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #7693.

Susquehanna International Group first reported a position in BIB in Q2 2013 and has held it in 44 quarters since. The position peaked at $3.88M in Q3 2020. 23 funds tracked by Wall St. Rank hold BIB as of Q1 2026.

  • Susquehanna International Group held 13,212 shares of ProShares Ultra NASDAQ Biotechnology worth $1.08M as of Q1 2026.
  • Susquehanna International Group bought 6,775 ProShares Ultra NASDAQ Biotechnology shares in Q1 2026, an estimated $561K.
  • ProShares Ultra NASDAQ Biotechnology made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7693 holding.
  • Susquehanna International Group first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2013 and has held it in 44 quarters since.
  • Susquehanna International Group's ProShares Ultra NASDAQ Biotechnology position peaked at $3.88M in Q3 2020.
  • 23 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.